HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | 0.0% | 29,000 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -99.9% | 29,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $2,915,000 | +10310.7% | 29,000 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | +3.7% | 29,000 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | 0.0% | 29,000 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | +3.8% | 29,000 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | +4.0% | 29,000 | 0.0% | 0.00% | – |
| Q2 2017 | $25,000 | -98.8% | 29,000 | -98.7% | 0.00% | -100.0% |
| Q1 2017 | $2,025,000 | -58.7% | 2,200,000 | -57.7% | 0.00% | -60.0% |
| Q4 2016 | $4,905,000 | +0.0% | 5,200,000 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $4,904,000 | +2.9% | 5,200,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $4,765,000 | +8.3% | 5,200,000 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $4,398,000 | – | 5,200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DW Partners, LP | 8,380,000 | $7,238,000 | 5.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 74,100,000 | $64,002,000 | 3.41% |
| SILVERBACK ASSET MANAGEMENT LLC | 8,500,000 | $7,349,000 | 2.78% |
| Lion Point Capital, LP | 16,000,000 | $13,790,000 | 1.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 27,250,000 | $23,486,000 | 1.60% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 54,652,000 | $47,320,000 | 0.90% |
| Opera Trading Capital | 6,000,000 | $5,177,000 | 0.90% |
| LINDEN ADVISORS LP | 23,606,000 | $20,448,000 | 0.86% |
| Jabre Capital Partners S.A. | 8,400,000 | $7,345,000 | 0.66% |
| SYMPHONY ASSET MANAGEMENT LLC | 5,000,000 | $4,334,000 | 0.49% |